HR10202-118

Introduced

To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide benefits for lung cancer screenings for certain individuals without the imposition of cost sharing.

118th Congress Introduced Nov 21, 2024

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide benefits for lung cancer screenings for certain individuals without the imposition of cost sharing., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Finance, Immigration.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H3E70A5E73B3744729DA818984D051274: 1. Short title This Act may be cited as the Katherine’s Lung Cancer Early Detection and Survival Act of 2024.
  • Section H2FB34065E4274F17AB0D188EEF2DA760: 2. Findings Congress finds the following: Lung cancer is the number 1 killer of all cancers. Lung cancer causes more deaths than prostate cancer, breast...
  • Section H1A94E5FEA7F04022B76445EF863FCCB8: 3. Requiring coverage of lung cancer screenings for certain individuals without cost sharing Section 2713(a) of the Public Health Service Act (42 U.S.C....

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide benefits for lung cancer screenings for certain individuals without the imposition of cost sharing., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Finance, Immigration

Primary Purpose

This bill, To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide benefits for lung cancer screenings for certain individuals without the imposition of cost sharing., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Finance Immigration

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients:
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies:
health care providers and patients:

Legislative Progress

Introduced
Introduced Committee Passed
Nov 21, 2024

Mr. Boyle of Pennsylvania (for himself and Mr. DeSaulnier) introduced …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Finance Immigration
Actor Mappings
"federal_implementing_agencies"
→ Federal agencies assigned duties by the bill

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology